Tag: percutaneous coronary intervention

Dual antiplatelet therapy (DAT) has become standard care for patients undergoing percutaneous coronary intervention (PCI). Following balloon injury and stent placement, the intima at the site is distressed, resulting in the activation of coagulation cascade and platelets. In the case of bare metal stents (BMS), it takes six to eight weeks for the stent surface to be covered with neointima...

We present the case of a 55 year-old male admitted to Malopolskie Centrum Sercowo-Naczyniowe PAKS in Chrzanów with diagnosis of anterior wall myocardial infarction (STEMI)...

The association between ST-segment resolution and clinical outcome in patients with acute ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PPCI) remains unclear...

Percutaneous coronary intervention (PCI) is one of the most frequently performed cardiac interventions. However, there is limited data regarding the cause of recurrent hospitalization and repeat revascularization. The aim of this study was to assess re-hospitalization and repeat revascularization within 30 days of the initial hospitalization for PCI, using data from Opolskie Voivodeship, National Health Fund (NHF) Registry. 

Surgical revascularization with coronary artery by-pass grafting is still recommended in vast majority of patients with unprotected left main disease...

Background: Obesity and overweight alone may confer a survival benefit after myocardial infarction, independent of age, medical care or therapy...

Aspirin or acetylsalicylic acid (ASA) is widely used in cardiology patients, however, up to 20% are intolerant, with true allergy affecting 0.5–2.4% of patients [1, 2]. ASA acts primarily through irreversible inhibition of cyclooxygenase-1 (COX-1), preventing conversion of arachidonic acid to thromboxane (TxA2) and thus inhibiting platelet aggregation. The production of TxA2 can be completely inhibited through 75 mg/day dosing of aspirin [3]...

Dual antiplatelet therapy with acetylsalicylic acid (ASA) and clopidogrel (CLO) is recommended after percutaneous coronary intervention (PCI) with stent implantation to reduce the risk of instent thrombosis [1, 2]. Despite dual antiplatelet therapy, some patients experience thrombotic cardiac events. Thus, agents that reduces the risk of thrombotic events without increasing the risk of bleeding merits further evaluation...

Restoration of blood flow to an infarct-related artery (IRA) in the first 12 h of evolution is a cornerstone of contemporary treatment of acute myocardial infarction (MI) [1, 2]. It decreases the infarct size, preventing the expansion of myocardial necrosis and its consequences [1, 2]. However, due to their late presentation, up to one third of patients do not receive reperfusion therapy [3]...

Percutaneous coronary intervention (PCI) in chronic total occlusion (CTO) represents an evolving field of interventional cardiology. Since complex techniques and high support are often required, large guiding catheters inserted by trans-femoral approach are usually adopted by CTO-dedicated operators [1]. As a consequence, the majority of interventionalists who perform CTO PCI consider trans-radial approach (TRA) unsuitable for such kind of interventions...